[1] CHIOTOS K, HAYES M, GERBER J S, et al. Treatment of carbapenem-resistant enterobacteriaceae infections in children[J].J Pediatric Infect Dis Soc,2020, 9(1):56-66. [2] ACKLEY R, ROSHDY D, MEREDITH J, et al. Meropenem-vaborbactam versus ceftazidime-avibactam for treatment of carbapenem-Resistant enterobacteriaceae infections[J].Antimicrob Agents Chemother,2020, 64(5):2313-2319. [3] EMST C M, BRAXTON J R, RODRIGUEZ-OSORIO C A, et al. Adaptive evolution of virulence and persistence in carbapenem-resistant klebsiella pneumoniae[J].Nat Med, 2020,26(5):705-711. [4] SHIELDS R K, MCCREARY E K, MARIRI R V, et al. Early experience with meropenem-vaborbactam for treatment of carbapenem-resistant enterobacteriaceae infections[J].Clin Infect Dis, 2020, 71(3):667-671. [5] 王毓三, 申子瑜, 叶应抚. 全国临床检验操作规程[M]. 3版. 南京:东南大学出版社, 2006. [6] HUMPHRIES R M, AMBLER J, MITCHELL S L, et al. CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests[J].J Clin Microbiol,2018, 56(4):1934-1937. [7] ADESANYA O A, IGWE H A. Carbapenem-resistant enterobacteriaceae (CRE) and gram-negative bacterial infections in south-west Nigeria: a retrospective epidemiological surveillance study[J].AIMS Public Health,2020, 7(4):804-815. [8] DUTCHER L, LAUTENBACH E. A deeper dive: Implications of identifying more of the carbapenem-resistant enterobacteriaceae iceberg[J].J Infect Dis,2020, 221(11):1743-1745. [9] 曾晓艳, 李芳, 雷金娥, 等. 近5年耐碳青霉烯类肠杆菌科细菌流行病学及耐药性分析[J].西北药学杂志, 2019, 34(5):120-125. [10] 陈慧君, 朱齐兵, 叶丽君, 等. 耐碳青霉烯类肠杆菌科细菌的分布及耐药性分析[J].中国医药, 2019, 15(6):953-956. [11] 王勋松, 黄丽芳, 金国兵, 等. 耐碳青霉烯类抗生素肠杆菌科细菌的分布特点及耐药性[J].海南医学, 2019, 30(8):58-61. [12] LIU J, ZHANG L, PAN J, et al. Risk factors and molecular epidemiology of complicated intra-abdominal infections with carbapenem-resistant enterobacteriaceae: A multicenter study in China[J].J Infect Dis,2020, 221(2):156-163. [13] IGBINOSA O, DOGHO P, OSADIAYE N. Carbapenem-resistant enterobacteriaceae: A retrospective review of treatment and outcomes in a long-term acute care hospital[J].Am J Infect Control,2020, 48(1):7-12. [14] 张艳双, 刘静, 万楠, 等. 耐碳青霉烯类肠杆菌科(CRE)耐药分子机制及控制流行的应对策略[J].现代检验医学杂志, 2019, 34(2):1-4.
2024, Vol. 41 
